Ionara Bio
Stealth Mode Startup
StartupIonara Bio is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2024. Stealth Mode Startup. Key investors include Peregrine Ventures. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
Product stage: R&D.
- StageSeed
- ProductR&D
- Employees1-10
- HQNess Ziona
- DistrictCenter District
- Last RoundUndisclosed
- Peregrine VenturesLead
What does Ionara Bio do?
Ionara Bio is developing novel, proprietary small molecules that target and block the TRPV2 channel—a key driver of inflammatory responses, particularly those involving macrophages, that impair cardiac structure and function following acute myocardial infarction (AMI). The company’s lead candidate, a first-in-class TRPV2 inhibitor, is designed to improve cardiac function and reduce pathological cardiac fibrosis, ultimately leading to significantly enhanced post-AMI recovery.
What sector is Ionara Bio in?
Ionara Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Healthcare, Providers.
Where is Ionara Bio located?
Ionara Bio is based in Ness Ziona, Israel, Center District.